Skip to content

COVID-19 Antigen Rapid Test Kit

The Use of SG Diagnostics COVID-19 Antigen Rapid Test Kit for Self-testing as a Method for Reduction SARS-CoV-2

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04889365
Acronym
SETCOV
Enrollment
200
Registered
2021-05-17
Start date
2021-05-11
Completion date
2021-07-10
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV2 Infection

Keywords

SARS-CoV-2, COVID-19, symptoms, test

Brief summary

The SG Diagnostics COVID-19 Antigen Rapid Test Kit (Colloidal Gold-Based) is a single-use test kit intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is intended for use with self-collected nasal swab samples in individuals who are suspected of COVID-19. This test utilizes a lateral flow immunoassay technology for the qualitative detection of spike and nucleocapsid protein antigens of SARS-CoV-2 in individuals with known or suspected COVID-19.

Interventions

DIAGNOSTIC_TESTSG Diagnostics COVID-19 Antigen Rapid Test Kit

SG Diagnostics COVID-19 Antigen Rapid Test Kit (self-use)

DIAGNOSTIC_TESTPolymerase chain reaction (PCR) test

Professional collection of a second swab sample, for confirmation by PCR

Sponsors

Polish Society of Disaster Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (aged ≥ 18 years) volunteers

Exclusion criteria

* Children (aged \< 18years)

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of SG Diagnostics COVID-19 Antigen Rapid Test Kitwithin 1 daySensitivity of SG Diagnostics COVID-19 Antigen Rapid Test Kit (self-use)
Specificity of SG Diagnostics COVID-19 Antigen Rapid Test Kitwithin 1 daySpecificity of SG Diagnostics COVID-19 Antigen Rapid Test Kit (self-use)

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026